MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles

In recent years, there has been increasing interest in developing a multifunctional nanoscale platform for cancer monitoring and chemotherapy. However, there is still a big challenge for current clinic contrast agents to improve their poor tumor selectivity and response. Herein, we report a new kind...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Wu, Bo, Lu, Shu-Ting, Deng, Kai, Yu, Hui, Cui, Can, Zhang, Yang, Wu, Ming, Zhuo, Ren-Xi, Xu, Hai-Bo, Huang, Shi-Wen
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5604569/
https://ncbi.nlm.nih.gov/pubmed/29066883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S143048
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars